Products

ViewCreator

Create and publish content across YouTube, Instagram, TikTok, X, and more with AI-powered agents.

viewcreator.ai Marketing / Social Media Management & Scheduling

AI Benchmark
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
BridgeMind
@bridgemindai· 66.9K followers
Launched
7mo ago
2026-04-10 · Est.

Traffic

Last 12 months
Monthly visitsData through Sep 2026 · Oct 2026 pending
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI agents that create once and publish everywhere

    Apr 10 · 7mo agoLaunch page

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct41%
  • Organic Search33%
  • Referrals10%
  • Social6%
  • Other10%

Countries

  • India100%

Search

Domain authority —Domain registered 2025-08-28

KeywordMonthly volume
creator40.2K
bridgemind25.6K
viewri940
viewcreator590
viewcreator.ai50

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-04-10

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does ViewCreator get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ViewCreator and what platforms does it support?
ViewCreator is catalogued under Social Media Management & Scheduling: Create and publish content across YouTube, Instagram, TikTok, X, and more with AI-powered agents.. Supported platforms: Web.

Related products in this category

Marketing / Social Media Management & Scheduling

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.